IDiyas

For the Inventor, By the Inventor

Edison, NJ, United States of America

Stephen D Goble

USPTO Granted Patents = 15

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 77(Granted Patents)


Location History:

  • Edsion, NJ (US) (2009)
  • Edison, NJ (US) (2004 - 2014)

Company Filing History:

goldMedal10 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2014

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2014-02-18),
2. 8501786 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2013-08-06),
3. 8399480 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2013-03-19),
4. 8247415 - Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists (2012-08-21),
5. 7700591 - Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors (2010-04-20),
6. 7598243 - Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity (2009-10-06),
7. 7589085 - Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity (2009-09-15),
8. 7557120 - Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity (2009-07-07),
9. 7491737 - Heterarylpiperidine modulators of chemokine receptor activity (2009-02-17),
10. 7410961 - 2,6-disubstituted piperiddines as modulators (2008-08-12),
11. 7393844 - Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity (2008-07-01),
12. 7390803 - Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity (2008-06-24),
13. 7230008 - Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity (2007-06-12),
14. 7166614 - Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity (2007-01-23),
15. 6812234 - Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity (2004-11-02),

As the client of idiyas.com, you requested an article about inventor Stephen D Goble. Here is the article based on the provided data.

Title: Innovator Spotlight: Stephen D Goble - Pioneering Science in Edison, NJ

Introduction:

Stephen D Goble is a distinguished inventor based in Edison, NJ, with a remarkable portfolio of 15 patents to his name. His groundbreaking work in the field of pharmaceuticals has significantly advanced the medical landscape.

Latest Patents:

Stephen D Goble's latest patents include "Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists." This invention offers compounds of Formula (I), along with pharmaceutical compositions, and methods for treating or preventing diseases mediated by the activation of β3-adrenoceptor.

Career Highlights:

Throughout his career, Stephen D Goble has made significant contributions to renowned companies like Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His innovative drive and expertise have propelled the pharmaceutical industry forward.

Collaborations:

Stephen D Goble has collaborated closely with esteemed colleagues such as Lihu Yang and Alexander Pasternak. Together, they have worked tirelessly to push the boundaries of scientific discovery and create impactful solutions for healthcare challenges.

Conclusion:

In conclusion, Stephen D Goble stands as a visionary inventor whose dedication to excellence has shaped the pharmaceutical landscape. His relentless pursuit of innovation continues to inspire new possibilities in the field of medicine, solidifying his legacy as a pioneer in the industry.

Feel free to explore more about Stephen D Goble and his remarkable contributions on idiyas.com!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…